Could a biodegradable device help heal spinal cords?
NCT ID NCT02490501
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial tested a device called SC0806, which is surgically implanted into the spine. It releases a growth factor to encourage nerve repair in people with complete spinal cord injury. Ten participants were randomly assigned to receive either the device plus rehabilitation or rehabilitation alone. The study looked at safety and whether the device could improve nerve signals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SC0806 (a biodegradable device containing heparin-activated recombinant fibroblast growth factor 1 and nerve implants)
What this could lead to
If successful, this could point toward a new treatment to help restore some nerve function after spinal cord injury.
What could go wrong
This is an early, small trial (10 people) focused on safety. It may not show meaningful improvement, and the surgery carries risks like infection or device complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital and RSS
Stockholm, Sweden